Long term (5 years) efficacy and safety OFO Infliximab in Crohn disease patients

R. Ferreiro, E. Fernandez-Salgado, V. Ollero, A. Lorenzo Gonzalez, D. Carpio, A. Echarri, A. Fernandez, L. De Castro, J.R. Pineda Marino, V. Hernandez, L. Sanromán, J. Martinez Cadilla, M.A. Pato, E. Santos, S. Pereira, J. Castro, M. Barreiro-de AcostaUEGW Estocolmo

descargar pdf